Ashish Rai, PhD, MSPH, MBBS

Harvard Pilgrim Health Care Institute

Poster(s):

• (B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-226) Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-313) Post-authorization Safety Study to Assess the Risk of Diabetic Ketoacidosis among Type 2 Diabetes Mellitus Patients Treated with Ertugliflozin Compared to Patients Treated with Other Antihyperglycemic Agents
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET